These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 16361144)
1. The radiology of gastrointestinal stromal tumours (GIST). King DM Cancer Imaging; 2005 Dec; 5(1):150-6. PubMed ID: 16361144 [TBL] [Abstract][Full Text] [Related]
2. Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation. Wilson J; Connock M; Song F; Yao G; Fry-Smith A; Raftery J; Peake D Health Technol Assess; 2005 Jul; 9(25):1-142. PubMed ID: 15985189 [TBL] [Abstract][Full Text] [Related]
3. Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy. Annaberdyev S; Gibbons J; Hardacre JM World J Surg Oncol; 2009 Mar; 7():30. PubMed ID: 19291285 [TBL] [Abstract][Full Text] [Related]
4. [Successful resection of locally advanced gastrointestinal stromal tumor of the ampulla of Vater after treatment with imatinib]. Park JE; Dong SH; Cho KH; Jang JY; Kim HJ; Kim BH; Chang YW; Chang R Korean J Gastroenterol; 2010 Jul; 56(1):39-44. PubMed ID: 20695129 [TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study. Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J Oncology; 2005; 69(4):326-32. PubMed ID: 16293972 [TBL] [Abstract][Full Text] [Related]
7. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy. Shankar S; Dundamadappa SK; Karam AR; Stay RM; van Sonnenberg E Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005 [TBL] [Abstract][Full Text] [Related]
8. Imatinib for the treatment of patients with unresectable or metastatic malignant KIT-positive gastrointestinal stromal tumours: an open-label Belgian trial. Prenen H; Dumez H; Stefan C; Hoeben A; Wouters C; Van Lierde MA; Sciot R; van Oosterom AT; Peeters M; Polus M; Duck L; Gil T; Schöffski P Acta Gastroenterol Belg; 2006; 69(4):367-71. PubMed ID: 17343077 [TBL] [Abstract][Full Text] [Related]
9. New strategies for treating GIST when imatinib fails. Boyar MS; Taub RN Cancer Invest; 2007 Aug; 25(5):328-35. PubMed ID: 17661208 [TBL] [Abstract][Full Text] [Related]
10. Primary GIST of the liver masquerading as primary intra-abdominal tumour: a rare extra-gastrointestinal stromal tumour (EGIST) of the liver. Louis AR; Singh S; Gupta SK; Sharma A J Gastrointest Cancer; 2014 Sep; 45(3):392-4. PubMed ID: 23749608 [No Abstract] [Full Text] [Related]
11. CT scan is not everything in the evaluation of a patient with gastrointestinal tumors (GIST) under imatinib therapy. Wang CM; Fu H; Zhao GF; Wang J; Shi YQ Pathol Oncol Res; 2012 Oct; 18(4):1095-7. PubMed ID: 21927980 [No Abstract] [Full Text] [Related]
13. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. Choi H; Charnsangavej C; Faria SC; Macapinlac HA; Burgess MA; Patel SR; Chen LL; Podoloff DA; Benjamin RS J Clin Oncol; 2007 May; 25(13):1753-9. PubMed ID: 17470865 [TBL] [Abstract][Full Text] [Related]
14. Advanced gastrointestinal stromal tumor patients with complete response after treatment with imatinib mesylate. Chiang KC; Chen TW; Yeh CN; Liu FY; Lee HL; Jan YY World J Gastroenterol; 2006 Apr; 12(13):2060-4. PubMed ID: 16610057 [TBL] [Abstract][Full Text] [Related]
15. Activity of nilotinib (AMN-107) alone in advanced gastrointestinal stromal tumors progressing on imatinib and sunitinib. Case report. Sevinc A Chemotherapy; 2009; 55(2):132-6. PubMed ID: 19188713 [TBL] [Abstract][Full Text] [Related]
17. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall. Pauwels P; Debiec-Rychter M; Stul M; De Wever I; Van Oosterom AT; Sciot R Histopathology; 2005 Jul; 47(1):41-7. PubMed ID: 15982322 [TBL] [Abstract][Full Text] [Related]
18. High-risk CD117-positive gastrointestinal stromal tumor of the colon in a 12-year-old girl: adjuvant treatment with imatinib mesylate. Okur A; Oguz A; Karadeniz C; Pinarli FG; Ozen O; Ekinci O Tumori; 2012; 98(2):59e-62e. PubMed ID: 22678007 [TBL] [Abstract][Full Text] [Related]
19. Early detection of response to imatinib therapy for gastrointestinal stromal tumor by using 18F-FDG-positron emission tomography and computed tomography imaging. Zincirkeser S; Sevinc A; Kalender ME; Camci C World J Gastroenterol; 2007 Apr; 13(15):2261-2. PubMed ID: 17465516 [TBL] [Abstract][Full Text] [Related]